UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Journal of vascular surgery, 2015-10, Vol.62 (4), p.1089-1089

2015

Volltextzugriff (PDF)

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy

Indian heart journal, 2016-07, Vol.68 (4), p.464-472

2016

Volltextzugriff (PDF)

Anticoagulation‐related nephropathy

Journal of thrombosis and haemostasis, 2016-03, Vol.14 (3), p.461-467

2016

Volltextzugriff (PDF)

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

European heart journal, 2015-09, Vol.36 (33), p.2239-2245

2015

Volltextzugriff (PDF)

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

CO8 Design and Rationale of a Global Prospective Observational Study of Real-World Management of Patients with Atrial Fibrillation at High Risk of Stroke- Gardenia

Value in health, 2023-06, Vol.26 (6), p.S15-S15

2023

Volltextzugriff (PDF)

Economic analysis of platelet aggregability-guided surgical revascularization compared with standard of care in ACS patients: subanalysis from PLAT-CABG randomized clinical trial

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

P3605The usefulness of the TIMI-AF score in the prediction of ischemic stroke and bleeding for Asian patients with atrial fibrillation

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis

Stroke (1970), 2019-08, Vol.50 (8), p.2187-2196

2019

Volltextzugriff (PDF)

5719Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk. A subanalysis of the ENGAGE AF-TIMI 48 study

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14

European heart journal, 2000-12, Vol.21 (23), p.1944-1953

2000

Volltextzugriff (PDF)

Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II

European heart journal, 2001-09, Vol.22 (18), p.1702-1715

2001

Volltextzugriff (PDF)

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II

European heart journal, 2002-06, Vol.23 (12), p.928-933

2002

Volltextzugriff (PDF)

Thrombocytoperia with GP IIb/IIIa inhibitors: a meta-analysis

Journal of the American College of Cardiology, 1998, Vol.31, p.185-185

1998

Volltextzugriff (PDF)

Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction

European heart journal, 2001-11, Vol.22 (22), p.2104-2115

2001

Volltextzugriff (PDF)

Caeteris paribus—all things being equal

European heart journal, 2001-12, Vol.22 (24), p.2221-2223

2001

Volltextzugriff (PDF)

Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials

Journal of the American College of Cardiology, 1998, Vol.31, p.191-191

1998

Volltextzugriff (PDF)

Dose ranging study of intravenous RPR 109891 in patients with acute coronary syndromes — results of TIMI 15A

Journal of the American College of Cardiology, 1998, Vol.31, p.93-94

1998

Volltextzugriff (PDF)

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

ACC current journal review, 2002-03, Vol.11 (2), p.14-14

2002

Volltextzugriff (PDF)

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) phase II angiographic trial

ACC current journal review, 2003-07, Vol.12 (4), p.12-13

2003

Volltextzugriff (PDF)

Anticoagulant--rNAPc2

Manufacturing chemist (London : 1981), 2007-02, Vol.78 (2), p.20

2007

Volltextzugriff (PDF)

Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram

ACC current journal review, 2001, Vol.10 (1), p.15-15

2001

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)
magazinearticle
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Cardiovascular System & Cardiology
(8)
Life Sciences & Biomedicine
(8)
Science & Technology
(8)
Humans
(7)
Cardiac & Cardiovascular Systems
(6)
Electrocardiography
(4)
Female
(4)
Fibrinolytic Agents - Therapeutic Use
(4)
Male
(4)
Middle Aged
(4)
Treatment Outcome
(4)
Aged
(3)
Follow-Up Studies
(3)
Myocardial Infarction - Therapy
(3)
Acute Mi
(2)
Adult
(2)
Anticoagulants
(2)
Anticoagulants - Therapeutic Use
(2)
Antiplatelet Therapy
(2)
Biological And Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy

Anticoagulation‐related nephropathy

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48

Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry

CO8 Design and Rationale of a Global Prospective Observational Study of Real-World Management of Patients with Atrial Fibrillation at High Risk of Stroke- Gardenia

Economic analysis of platelet aggregability-guided surgical revascularization compared with standard of care in ACS patients: subanalysis from PLAT-CABG randomized clinical trial

P3605The usefulness of the TIMI-AF score in the prediction of ischemic stroke and bleeding for Asian patients with atrial fibrillation

Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis

5719Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk. A subanalysis of the ENGAGE AF-TIMI 48 study

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14

Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II

Thrombocytoperia with GP IIb/IIIa inhibitors: a meta-analysis

Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction

Caeteris paribus—all things being equal

Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials

Dose ranging study of intravenous RPR 109891 in patients with acute coronary syndromes — results of TIMI 15A

A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy

Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) phase II angiographic trial

Anticoagulant--rNAPc2

Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram

Suchergebnisse filtern